Sterling Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32K Sell
74
-59
-44% -$2.49K ﹤0.01% 2954
2026
Q1
$7.36K Sell
133
-3
-2% -$143 ﹤0.01% 2539
2025
Q4
$5.08K Sell
136
-16,744
-99% -$680K ﹤0.01% 2889
2025
Q3
$683K Buy
16,880
+1
+0% +$33 0.01% 793
2025
Q2
$431K Sell
16,879
-223
-1% -$4.86K 0.01% 984
2025
Q1
$365K Sell
17,102
-1,660
-9% -$37.1K 0.01% 992
2024
Q4
$394K Buy
18,762
+448
+2% +$10.4K 0.01% 1050
2024
Q3
$412K Buy
+18,314
New +$354K 0.01% 962

Other funds holding PAHC

Sterling Capital Management's PAHC Position: Q2 2026 in Review

Sterling Capital Management reduced its Phibro Animal Health (PAHC) stake by 44% in Q2 2026, selling an estimated $2.49K and leaving 74 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2954.

Sterling Capital Management first reported a position in PAHC in Q3 2024 and has held it in 8 quarters since. The position peaked at $683K in Q3 2025. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Sterling Capital Management held 74 shares of Phibro Animal Health worth $2.32K as of Q2 2026.
  • Sterling Capital Management sold 59 Phibro Animal Health shares in Q2 2026, an estimated $2.49K.
  • Phibro Animal Health made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2954 holding.
  • Sterling Capital Management first reported a position in Phibro Animal Health in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Phibro Animal Health position peaked at $683K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.